Company news
BridgeBio Oncology Therapeutics, Inc. news in 2025
BridgeBio Oncology Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.
BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
BBOT Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 10, 2025
BBOT Announces Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS: PI3Kα Breaker, at the San Antonio Breast Cancer Symposium (SABCS)
December 9, 2025
BBOT to Participate in Upcoming December Investor Healthcare Conferences
November 18, 2025
BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress
November 11, 2025
BBOT to Participate in the Jefferies Global Healthcare Conference in London
November 3, 2025
BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS)
October 30, 2025
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS: PI3Kα Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglycemia
October 25, 2025
BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 23, 2025
BBOT Announces Poster Presentations at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 12, 2025
BBOT to Participate in Upcoming September Investor Healthcare Conferences
August 20, 2025
BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition
August 11, 2025
BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines
February 27, 2025
Decks in 2025
- SPAC Merger (February 2025)
SPAC merger · 50 slides · Feb 28, 2025